跳至主要内容
临床试验/NCT00490464
NCT00490464已完成不适用

Safety and Efficacy of Nicardipine for the Control of Blood Pressure After SAH

University of Illinois at Chicago1 个研究点 分布在 1 个国家目标入组 163 人开始时间: 2004年6月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
163
试验地点
1

研究概览

简要总结

The purpose of this research is to explore ways to improve and simplify control of blood pressure in patients with SAH or ICH. This research will be done by comparing tow different medications that are routinely used to help control blood pressure. None of the medications used in this study nor any procedures performed are experimental.

研究设计

研究类型
Observational
观察模型
Defined Population
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18-70 years old (inclusive)
  • Admission to NSICU with a diagnosis of SAH or ICH

排除标准

  • Patients who are admitted >48 hours after SAH or ICH
  • Readmission or second SAH
  • Readmission or second ICH
  • Large (immediately life threatening) associated intraparenchymal or intraventricular hemorrhage
  • Women who are pregnant

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验